BioLedger - Human Biospecimen Supplier from Ukraine
Ethically sourced biofluid and tissue biospecimens for pharma, biotech and CRO clients worldwide.
Who We Are
To accelerate global biomedical research by providing fast, reliable and fully compliant access to high-quality human biospecimens from Ukraine.
BioLedger is a compliance-first human biospecimen supplier headquartered in Ukraine. We provide pharmaceutical, biotechnology and contract research organizations worldwide with ethically sourced and clinically annotated biospecimens - from FFPE blocks and fresh frozen tissue to PBMC, biofluids and other sample types
We act as a structured, process-driven partner between Ukrainian clinical hospitals and international clients - not a broker, not a bulk vendor. Every biospecimen we deliver comes with full chain-of-custody documentation, IRB approval and a clinical data package built to your project specifications.
Learn more about usFrom request to shipment-ready biospecimens
A clear, five-step process built for procurement, R&D and scientific teams.
Submit Request
Share indication, sample type, and donor criteria.
Protocol Setup
BioLedger has the collection protocols and IRB approvals and ICFs.
Clinical Collection
Partnering physicians collect biospecimens across our Ukrainian hospital network according to the ethical regulations.
Processing & QC
Pathology review, processing, aliquoting, storage, quality check and full annotation.
Logistics
IATA P650-compliant cold chain delivery in dry ice, liquid nitrogen, or ambient temperature to any global destination.
Compliance, speed, competitive cost and wide hospital network
Compliance First
IRB-approved collection, GCP-aligned protocol, and compliant data handling built into every project from the start.
Speed
Standard project launch within approximately 1 week vs. 2-4 weeks industry average.
Cost
Ukrainian operational base keeps prices up to 30-50% lower than Western European suppliers.
Network
Partnering clinical sites across oncology, hematology and therapeutic disease areas.